MacroGenics | MGNX - Stock


MacroGenics reported $9.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Amgen USD 6.22B 34M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Daiichi Sankyo JPY 692.38B 83.83B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Genmab DKK 21M 8M Mar/2026
Geron USD 123.6M 9.68M Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
J&J USD 15.14B 561M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.21B 272M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025